X0306 4 2016-11-17 0 0000883107 NANOPHASE TECHNOLOGIES Corp NANX 0001173970 WHITMORE R JANET 1319 MARQUETTE DRIVE ROMEOVILLE IL 60446 1 0 0 0 Common Stock 32675 I By Daughter Common Stock 2016-11-17 4 P 0 11300 0.72 A 1092465 D Stock Option (right to buy) 1.36 2012-01-31 2021-01-31 Common Stock 10000 10000 D Deferred Common Stock Common Stock 2000 20030 D Stock Appreciation Right 1.18 Common Stock 14000 0 D Stock Option (right to buy) 0.30 2013-08-07 2022-08-07 Common Stock 10000 10000 D Stock Option (right to buy) 0.415 2014-02-14 2023-02-14 Common Stock 10000 10000 D Stock Option (right to buy) 0.52 2015-02-13 2024-02-13 Common Stock 10000 10000 D Stock Option (right to buy) 0.44 2016-02-18 2025-02-18 Common Stock 9000 9000 D Stock Option (right to buy) 0.42 2017-02-23 2026-02-23 Common Stock 8100 8100 D Stock Option (right to buy) 0.90 2016-11-17 2026-11-17 Common Stock 2000 2000 D Stock Option (right to buy) 1.05 2016-11-17 2026-11-17 Common Stock 2000 2000 D Stock Option (right to buy) 1.18 2016-11-17 2026-11-17 Common Stock 2000 2000 D Stock Option (right to buy) 0.84 2016-11-17 2026-11-17 Common Stock 2000 2000 D Stock Option (right to buy) 1.85 2016-11-17 2026-11-17 Common Stock 2000 2000 D Stock Option (right to buy) 1.10 2016-11-17 2026-11-17 Common Stock 2000 2000 D Stock Option (right to buy) 0.99 2016-11-17 2026-11-17 Common Stock 2000 2000 D Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments. Each share of deferred common stock represents a right to receive one share of common stock. The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company. Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan. The stock appreciation rights that were to become payable upon the reporting person's termination of service as a director of the Company. 2,000 were issued 4/8/2009 at a conversion price of $0.90, 2,000 were issued 7/1/2009 at a conversion price of $1.05, 2,000 were issued 10/1/2009 at a conversion price of $1.18, 2,000 were issued 1/4/2010 at a conversion price of $0.84, 2,000 were issued 4/1/2010 at a conversion price of $1.85, 2,000 were issued 7/1/2010 at a conversion price of $1.10, and 2,000 were issued 10/1/2010 at a conversion price of $0.99. Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments. The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99. By Frank Cesario under UPA for R. Janet Whitmore 2016-11-21